The patients in this study experienced the same problems we are seeing with our Stryker hip lawsuit clients.
New York, New York (PRWEB) May 23, 2013
As Stryker hip lawsuit claims associated with last year’s recall of Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount in courts throughout the country, Bernstein Liebhard LLP notes that new research has found a connection between the type of corrosion that prompted the recall and local soft tissue destruction. The study, which was published on May 15th in the Journal of Bone and Joint Surgery, looked at 12 hips in 11 patients who reported new-onset and increasing pain within months of undergoing total hip replacement surgery involving femoral stems with dual-taper modularity. All of the patients demonstrated elevated levels of chromium, cobalt and titanium in their blood, as well as local soft tissue destruction with visible corrosion at the modular femoral neck-body junction upon revision surgery.*
“The patients in this study experienced the same problems we are seeing with our Stryker hip lawsuit clients. Among other things, the findings indicate affected patients should be evaluated for local tissue reactions to ensure their hips are functioning properly, ” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who have allegedly suffered Stryker hip problems associated with the Rejuvenate and ABG II hip stem recall.
Stryker Hip Problems
The Stryker Rejuvenate and ABG II hip stem recall was announced in July 2012, after the hip stems were found to be prone to fretting and corrosion at the modular neck junction. According to the recall notice, this occurrence could cause recipients to suffer pain and adverse local tissue reactions, the same issues described in the Journal of Bone and Joint Surgery study. Stryker has advised all patients fitted with the recalled components to undergo blood tests for elevated metal ion levels and cross sectional imaging to ensure their hips are functioning properly, even if they have not experienced symptoms of a Stryker failure as described in the recall notice.**
Since the recall announcement, a growing number of Rejuvenate and ABG II patients have filed Stryker hip lawsuits seeking compensation for their alleged injuries. Court documents indicate that at least 145 such claims have already been filed in a consolidated litigation underway in New Jersey’s Bergen County Superior Court. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296) Dozens of additional lawsuits have also been filed in federal courts throughout the country. On May 30th, the U.S. Judicial Panel on Multidistrict Litigation (JPML) will hear Oral Arguments regarding the proposed consolidation of all federally-filed Stryker hip lawsuits in a single federal court for pretrial proceedings. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))
Alleged victims of Stryker hip problems associated with the Rejuvenate and ABG II hip stem recall may be entitled to compensation for medical bills, lost wages, and pain and suffering. Additional information for individuals interested in filing a Stryker hip lawsuit is available at Bernstein Liebhard LLP’s website. To learn more, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP